Scientific Sessions

Cardio-oncology is an emerging field that focuses on the prevention, diagnosis, and management of cardiovascular complications in cancer patients and survivors. Many cancer therapies, including chemotherapy, targeted agents, and radiation, can adversely affect the heart, leading to conditions such as cardiomyopathy, arrhythmias, hypertension, and accelerated atherosclerosis. Early recognition of these complications is critical, as cardiovascular disease can limit cancer treatment options and significantly impact patient survival and quality of life. Advanced imaging techniques, biomarker monitoring, and risk assessment tools enable clinicians to detect subclinical cardiac injury, allowing timely interventions to mitigate long-term damage.

Management in cardio-oncology involves a multidisciplinary approach, integrating oncologists, cardiologists, and primary care providers to optimize both cancer outcomes and cardiovascular health. Preventive strategies include careful selection of cancer therapies, dose adjustments, and use of cardioprotective agents when appropriate. Lifestyle modifications, such as regular exercise, heart-healthy nutrition, and blood pressure and lipid control, are emphasized alongside pharmacologic therapies for preexisting or treatment-induced cardiovascular risk factors. Emerging research in precision medicine, cardioprotective drug development, and imaging-based monitoring continues to enhance the safety of cancer treatments. By addressing the intersection of oncology and cardiology, cardio-oncology ensures comprehensive care that preserves heart health while supporting effective cancer therapy.